» Articles » PMID: 34183821

The Importance of Molecular Diagnostics for Infectious Diseases in Low-resource Settings

Overview
Date 2021 Jun 29
PMID 34183821
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

From Tradition to Innovation: Diverse Molecular Techniques in the Fight Against Infectious Diseases.

Alsharksi A, Sirekbasan S, Gurkok-Tan T, Mustapha A Diagnostics (Basel). 2025; 14(24.

PMID: 39767237 PMC: 11674978. DOI: 10.3390/diagnostics14242876.


Analysis of Negative-Strand RNA Viruses by RT-qPCR: Rift Valley Fever Virus and Toscana Virus.

Duboeuf M, Confort M, Luengo C, Maisse C Methods Mol Biol. 2024; 2824:67-80.

PMID: 39039406 DOI: 10.1007/978-1-0716-3926-9_5.


Self-Powered Microfluidics for Point-of-Care Solutions: From Sampling to Detection of Proteins and Nucleic Acids.

Vloemans D, Van Hileghem L, Ordutowski H, Dal Dosso F, Spasic D, Lammertyn J Methods Mol Biol. 2024; 2804:3-50.

PMID: 38753138 DOI: 10.1007/978-1-0716-3850-7_1.


FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States.

Paniz-Mondolfi A, Ramirez J PLoS Negl Trop Dis. 2024; 18(5):e0012116.

PMID: 38722919 PMC: 11081280. DOI: 10.1371/journal.pntd.0012116.


Unveiling the menace: a thorough review of potential pandemic fungal disease.

Jafarlou M Front Fungal Biol. 2024; 5:1338726.

PMID: 38711422 PMC: 11071163. DOI: 10.3389/ffunb.2024.1338726.


References
1.
Okomo U, Senghore M, Darboe S, Bojang E, Zaman S, Hossain M . Investigation of sequential outbreaks of Burkholderia cepacia and multidrug-resistant extended spectrum β-lactamase producing Klebsiella species in a West African tertiary hospital neonatal unit: a retrospective genomic analysis. Lancet Microbe. 2022; 1(3):e119-e129. DOI: 10.1016/S2666-5247(20)30061-6. View

2.
Andrews J, Yu A, Saha S, Shakya J, Aiemjoy K, Horng L . Environmental Surveillance as a Tool for Identifying High-risk Settings for Typhoid Transmission. Clin Infect Dis. 2020; 71(Suppl 2):S71-S78. PMC: 7446943. DOI: 10.1093/cid/ciaa513. View

3.
Okeke I, Feasey N, Parkhill J, Turner P, Limmathurotsakul D, Georgiou P . Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Glob Health. 2020; 5(12). PMC: 7712442. DOI: 10.1136/bmjgh-2020-003622. View

4.
Albert H, Nathavitharana R, Isaacs C, Pai M, Denkinger C, Boehme C . Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?. Eur Respir J. 2016; 48(2):516-25. PMC: 4967565. DOI: 10.1183/13993003.00543-2016. View

5.
Saha S, Pai M . Can COVID-19 innovations and systems help low- and middle-income countries to re-imagine healthcare delivery?. Med. 2021; 2(4):369-373. PMC: 7927585. DOI: 10.1016/j.medj.2021.02.008. View